Targeting the Glucocorticoid Receptor Reduces Binge-Like Drinking in High Drinking in the Dark (HDID-1) Mice. 2020

Antonia M Savarese, and Angela R Ozburn, and Pamela Metten, and Jason P Schlumbohm, and Wyatt R Hack, and Kathryn LeMoine, and Hazel Hunt, and Felix Hausch, and Michael Bauder, and John C Crabbe
Department of Behavioral Neuroscience, Portland Alcohol Research Center, Oregon Health & Science University, Portland, Oregon.

Chronic alcohol exposure can alter glucocorticoid receptor (GR) function in some brain areas that promotes escalated and compulsive-like alcohol intake. GR antagonism can prevent dependence-induced escalation in drinking, but very little is known about the role of GR in regulating high-risk nondependent alcohol intake. Here, we investigate the role of GR in regulating binge-like drinking and aversive responses to alcohol in the High Drinking in the Dark (HDID-1) mice, which have been selectively bred for high blood ethanol (EtOH) concentrations (BECs) in the Drinking in the Dark (DID) test, and in their founder line, the HS/NPT. In separate experiments, male and female HDID-1 mice were administered one of several compounds that inhibited GR or its negative regulator, FKBP51 (mifepristone [12.5, 25, 50, 100 mg/kg], CORT113176 [20, 40, 80 mg/kg], and SAFit2 [10, 20, 40 mg/kg]) during a 2-day DID task. EtOH consumption and BECs were measured. EtOH conditioned taste and place aversion (CTA and CPA, respectively) were measured in separate HDID-1 mice after mifepristone administration to assess GR's role in regulating the conditioned aversive effects of EtOH. Lastly, HS/NPT mice were administered CORT113176 during DID to assess whether dissimilar effects from those of HDID-1 would be observed, which could suggest that selective breeding had altered sensitivity to the effects of GR antagonism on binge-like drinking. GR antagonism (with both mifepristone and CORT113176) selectively reduced binge-like EtOH intake and BECs in the HDID-1 mice, while inhibition of FKBP51 did not alter intake or BECs. In contrast, GR antagonism had no effect on EtOH intake or BECs in the HS/NPT mice. Although HDID-1 mice exhibit attenuated EtOH CTA, mifepristone administration did not enhance the aversive effects of EtOH in either a CTA or CPA task. These data suggest that the selection process increased sensitivity to GR antagonism on EtOH intake in the HDID-1 mice, and support a role for the GR as a genetic risk factor for high-risk alcohol intake.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D008297 Male Males
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011965 Receptors, Glucocorticoid Cytoplasmic proteins that specifically bind glucocorticoids and mediate their cellular effects. The glucocorticoid receptor-glucocorticoid complex acts in the nucleus to induce transcription of DNA. Glucocorticoids were named for their actions on blood glucose concentration, but they have equally important effects on protein and fat metabolism. Cortisol is the most important example. Corticoid Type II Receptor,Glucocorticoid Receptors,Glucocorticoids Receptor,Corticoid II Receptor,Corticoid Type II Receptors,Glucocorticoid Receptor,Receptors, Corticoid II,Receptors, Corticoid Type II,Receptors, Glucocorticoids,Corticoid II Receptors,Glucocorticoids Receptors,Receptor, Corticoid II,Receptor, Glucocorticoid,Receptor, Glucocorticoids
D005260 Female Females
D000075528 Aversive Agents Chemicals added to pharmacologic preparations, poisonous household goods, and other chemicals to discourage their abuse or consumption. Aversion Agents,Bitterants,Bittering Agents,Pungent Agents,Taste Deterrents
D000428 Alcohol Drinking Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking. Alcohol Consumption,Alcohol Intake,Drinking, Alcohol,Alcohol Drinking Habits,Alcohol Drinking Habit,Alcohol Intakes,Consumption, Alcohol,Drinking Habit, Alcohol,Habit, Alcohol Drinking,Habits, Alcohol Drinking,Intake, Alcohol
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015735 Mifepristone A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING SYNDROME. Mifegyne,Mifeprex,Mifégyne,R-38486,R38486,RU-38486,RU-486,ZK-98296,ZK98296,R 38486,RU 38486,RU 486,RU38486,RU486,ZK 98296

Related Publications

Antonia M Savarese, and Angela R Ozburn, and Pamela Metten, and Jason P Schlumbohm, and Wyatt R Hack, and Kathryn LeMoine, and Hazel Hunt, and Felix Hausch, and Michael Bauder, and John C Crabbe
September 2017, Pharmacology, biochemistry, and behavior,
Antonia M Savarese, and Angela R Ozburn, and Pamela Metten, and Jason P Schlumbohm, and Wyatt R Hack, and Kathryn LeMoine, and Hazel Hunt, and Felix Hausch, and Michael Bauder, and John C Crabbe
January 2019, Frontiers in behavioral neuroscience,
Antonia M Savarese, and Angela R Ozburn, and Pamela Metten, and Jason P Schlumbohm, and Wyatt R Hack, and Kathryn LeMoine, and Hazel Hunt, and Felix Hausch, and Michael Bauder, and John C Crabbe
July 2019, Journal of neuroendocrinology,
Antonia M Savarese, and Angela R Ozburn, and Pamela Metten, and Jason P Schlumbohm, and Wyatt R Hack, and Kathryn LeMoine, and Hazel Hunt, and Felix Hausch, and Michael Bauder, and John C Crabbe
March 2014, Drug and alcohol dependence,
Antonia M Savarese, and Angela R Ozburn, and Pamela Metten, and Jason P Schlumbohm, and Wyatt R Hack, and Kathryn LeMoine, and Hazel Hunt, and Felix Hausch, and Michael Bauder, and John C Crabbe
November 2023, Neuropharmacology,
Antonia M Savarese, and Angela R Ozburn, and Pamela Metten, and Jason P Schlumbohm, and Wyatt R Hack, and Kathryn LeMoine, and Hazel Hunt, and Felix Hausch, and Michael Bauder, and John C Crabbe
April 2020, Brain, behavior, & immunity - health,
Antonia M Savarese, and Angela R Ozburn, and Pamela Metten, and Jason P Schlumbohm, and Wyatt R Hack, and Kathryn LeMoine, and Hazel Hunt, and Felix Hausch, and Michael Bauder, and John C Crabbe
May 2014, Alcohol (Fayetteville, N.Y.),
Antonia M Savarese, and Angela R Ozburn, and Pamela Metten, and Jason P Schlumbohm, and Wyatt R Hack, and Kathryn LeMoine, and Hazel Hunt, and Felix Hausch, and Michael Bauder, and John C Crabbe
February 2022, Behavioural brain research,
Antonia M Savarese, and Angela R Ozburn, and Pamela Metten, and Jason P Schlumbohm, and Wyatt R Hack, and Kathryn LeMoine, and Hazel Hunt, and Felix Hausch, and Michael Bauder, and John C Crabbe
May 2017, Alcohol (Fayetteville, N.Y.),
Antonia M Savarese, and Angela R Ozburn, and Pamela Metten, and Jason P Schlumbohm, and Wyatt R Hack, and Kathryn LeMoine, and Hazel Hunt, and Felix Hausch, and Michael Bauder, and John C Crabbe
September 2008, Developmental psychobiology,
Copied contents to your clipboard!